The technology group Wärtsilä has been awarded a major contract to supply and construct a plant for the production of CO2-neutral liquid transport fuels. The plant will liquefy gas from the natural gas grid to produce carbon-neutral LNG.
Located in Cologne, Germany, the plant will have a capacity of approximately 100 000 tpy. The order with Wärtsilä was reportedly placed in September 2020.
“It is an honour to have been awarded this order for a landmark project. We take this as a clear endorsement of Wärtsilä’s capabilities in this field. The use of LNG as an emissions-reducing fuel in the marine and transportation industries is already well established, and to introduce bioLNG which can be mixed with LNG is the next obvious step in enabling a CO2-neutral transportation fuel. We look forward to continuing on our mission to enable sustainable societies with smart technology,” said Antti Kuokkanen, Wartsila VP Gas Solutions.
The feedstock for bioLNG is based on biological waste material (e.g. liquid manure and food waste). The feedstock is fed to an anaerobic digestion reactor that produces biogas, which is then upgraded to biomethane and injected into the natural gas grid. Green gas certificates are issued along with the injected biomethane, which then permits operators at other locations, such as liquefaction plants producing bioLNG, to buy the certificates and utilise the biomethane.
The Wärtsilä scope for this project includes the engineering, civil works, installation, and commissioning of the plant. The plant will include a gas treatment system based on Wärtsilä’s Puregas CA technology, a liquefaction unit utilising Wärtsilä’s Semi-Dual Brayton technology, storage tanks, truck filling stations, and all necessary safety flare and auxiliary equipment. The plant is expected to be fully operational by Autumn 2022.
Read the article online at: https://www.lngindustry.com/liquid-natural-gas/08102020/wrtsil-to-supply-a-major-lngbiolng-production-plant/
You might also like
Woodside has signed a binding sale and purchase agreement with JERA for the sale of a 15.1% non-operating participating interest in the Scarborough joint venture.